In sum, we delineated a novel regulatory axis of circANXA4/miR-1256/PRM1 involved in CRC progression, Further research on circANXA4 may provide novel insights into CRC diagnosis and treatment, as well as significantly advance therapies in clinical practice. This evidence concerns the gene PRM1 and colorectal carcinoma.